Cargando…

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension

Rationale: Enhanced proliferation and distal migration of human pulmonary arterial smooth muscle cells (hPASMCs) both contribute to the progressive increases in pulmonary vascular remodeling and resistance in pulmonary arterial hypertension (PAH). Our previous studies revealed that Rictor deletion,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yinan, Gu, Chenxin, Zhao, Tongtong, Jia, Yangfan, Bao, Changlei, Luo, Ang, Guo, Qiang, Han, Ying, Wang, Jian, Black, Stephen M., Desai, Ankit A., Tang, Haiyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632256/ https://www.ncbi.nlm.nih.gov/pubmed/34858182 http://dx.doi.org/10.3389/fphar.2021.758763

Ejemplares similares

Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model
por: Luo, Ang, et al.
Publicado: (2023)

Salusin-β, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats
por: Wang, Xingxing, et al.
Publicado: (2022)

Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension
por: Zhu, Jinsheng, et al.
Publicado: (2021)

Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension
por: Sun, Yanan, et al.
Publicado: (2021)

Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models
por: Bao, Changlei, et al.
Publicado: (2022)

Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension
por: Liu, Xuanxuan, et al.
Publicado: (2021)

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics
por: Adiwidjaja, Jeffry, et al.
Publicado: (2020)

Pharmacokinetics of single dose sildenafil orally administered in canine models of chronic embolic pulmonary hypertension
por: AKABANE, Ryota, et al.
Publicado: (2020)

The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell Proliferation
por: Zhou, Ying, et al.
Publicado: (2017)

Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia
por: Govindarajan, Baskaran, et al.
Publicado: (2012)

Therapeutic Strategies in Pulmonary Hypertension
por: Fuso, Leonello, et al.
Publicado: (2011)

Role of heparanase in pulmonary hypertension
por: Wang, Lin-Jun, et al.
Publicado: (2023)

Rapamycin Protects Against Peritendinous Fibrosis Through Activation of Autophagy
por: Zheng, Wei, et al.
Publicado: (2018)

The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
por: Buclin, Thierry, et al.
Publicado: (2020)

Integrative Proteomic and Phosphoproteomic Analyses of Hypoxia-Treated Pulmonary Artery Smooth Muscle Cells
por: Luo, Ang, et al.
Publicado: (2022)

Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension
por: Zhu, Zhongkai, et al.
Publicado: (2019)

Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis
por: Sun, Linli, et al.
Publicado: (2021)

CircRNA Microarray Profiling Reveals hsa_circ_0058493 as a Novel Biomarker for Imatinib-Resistant CML
por: Zhong, An-Ni, et al.
Publicado: (2021)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
por: Dong, Wenxing, et al.
Publicado: (2023)

Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients With Gastrointestinal Stromal Tumors
por: Qian, Yi, et al.
Publicado: (2019)

Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells
por: Glamoclija, Una, et al.
Publicado: (2022)

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis
por: Zhang, Ruihua, et al.
Publicado: (2022)

Editorial: Hypertension: Novel Mechanisms of Nervous and Humoral Regulation
por: Li, Peng, et al.
Publicado: (2022)

Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Pulmonary Arterial Hypertension
por: Zhang, Feng, et al.
Publicado: (2021)

Disrupting Reconsolidation by Systemic Inhibition of mTOR Kinase via Rapamycin Reduces Cocaine-Seeking Behavior
por: Zhang, Fushen, et al.
Publicado: (2021)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis
por: Peddi, Santosh, et al.
Publicado: (2018)

Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
por: Zhu, Xiaolu, et al.
Publicado: (2020)

Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
por: Zhang, Chenzhu, et al.
Publicado: (2022)

Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption
por: Peres, Rodrigo A. S., et al.
Publicado: (2023)

Effect of imatinib mesylate and rapamycin on the preformed intimal hyperplasia in rat carotid injury model
por: Park, Yang Jin, et al.
Publicado: (2015)

Medicinal Plants and Phytochemicals for the Treatment of Pulmonary Hypertension
por: Jasemi, Seyed Vahid, et al.
Publicado: (2020)

Advances in the research of sulfur dioxide and pulmonary hypertension
por: Liu, Xin, et al.
Publicado: (2023)

Leflunomide-induced pulmonary arterial hypertension in a young man with nephrotic syndrome: A case report
por: Luo, Xiaoqin, et al.
Publicado: (2022)

An Emerging Role for the Mammalian Target of Rapamycin in “Pathological” Protein Translation: Relevance to Cocaine Addiction
por: Dayas, Christopher V., et al.
Publicado: (2012)

Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension
por: Fabro, Alexandre Todorovic, et al.
Publicado: (2021)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension
por: Liu, Yan, et al.
Publicado: (2022)

Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
por: Liu, Yandong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1mqtligiokfkaasv9kegbjr1a4